Last updated on February 2020

Safety and Efficacy of Emixustat in Stargardt Disease

Brief description of study

The purpose of this study is to determine if emixustat hydrochloride reduces the rate of progression of macular atrophy compared to placebo in subjects with Stargardt disease.

Clinical Study Identifier: NCT03772665

Find a site near you

Start Over

Pretoria Eye Institute

Pretoria, South Africa
  Connect »